MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹682 Cr | ₹436 Cr | ₹354 Cr | ₹280 Cr | ₹245 Cr |
What is the latest Short Term Provisions ratio of MANKIND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹682 Cr |
| Mar2024 | ₹436 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹245 Cr |
How is Short Term Provisions of MANKIND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹682 Cr | 56.52 | |
| Mar2024 | ₹436 Cr | 23.12 | |
| Mar2023 | ₹354 Cr | 26.57 | |
| Mar2022 | ₹280 Cr | 13.98 | |
| Mar2021 | ₹245 Cr | - | |
Compare Short Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹85,810.8 Cr | 2.8% | -6.1% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.8% |
-6.1% |
-15.7% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses